| Literature DB >> 32075998 |
Suliang Yang1, Yangyang Huo1, Huanjie Wang1, Jiefei Ji1, Wen Chen1, Yanqun Huang2.
Abstract
Mitochondrial heterogeneity is the presence of two or more types of mitochondrial (mt)DNA in the same individual/tissue/cell. It is closely related to animal health and disease. ND2 is a protein-coding gene in mtDNA, which participates in mitochondrial respiratory chain and oxidative phosphorylation. In previous studies, we observed that the mt.A5703T and mt.T5727G sites in the ND2 gene were the heteroplasmic variation sites. We used pyrophosphate sequencing technology to examine chicken mt.A5703T and mt.T5727G heteroplasmic sites in the ND2 gene, in different tissues and at different development stages in chickens. We also investigated whether nutritional factors could affect the mt.A5703T and mt.T5727G heteroplasmy. Our results showed that chicken mt.A5703T and mt.T5727G heteroplasmy had clear spatio-temporal specificities, which varied between tissues/development stages. The mtDNA heterogeneity was relatively stable upon nutrition intervention, 30% dietary energy restriction (from 18 to 48 days old) and different types of dietary fats (at 5% concentration, from 1 to 42 days old) did not change the breast muscle heteroplasmy of broilers at the mt.A5703T and mt.T5727G sites. In addition, multiple potential heteroplasmic sites were detected by clone sequencing in the ND2 region, which potentially reflected abundant heteroplasmy in the chicken mitochondrial genome. These results provide an important reference for further research on heteroplasmy in chicken mitochondria.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32075998 PMCID: PMC7031424 DOI: 10.1038/s41598-020-59703-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Variants in the mtND2 gene and predicted amino acid changes.
| Variation sites | Nucleotide change | Amino acid change |
|---|---|---|
| T5484C | TGA → CGA | W → R |
| C5509T | ACA → ATA | T → M |
| C5523A | CCG → ACG | P → T |
| A5559G | ATC → GTC | I → V |
| A5562G | AAA → GAA | K → E |
| T5586C | TTC → CTC | F → L |
| T5613C | TCC → CCC | S → P |
| T5674C | CTC → CCC | L → P |
| T5685C | TCA → CCA | S → P |
| A5703T | ACC → TCC | T → S |
| T5727G | CTA → TTA | S → A |
| T5758C | CTA → CCA | L → P |
| A5764G | CAA → CGA | Q → R |
| T5791C | TTC → TCC | F → S |
| T5796C | TCC → CCC | S → P |
| A5823G | ATA → GTA | M → V |
The haplotype distribution of the mtND2 gene for six samples (by clone sequencing)a.
| Haplotype | 55555555555555555555555555566 | Number | Sample one | Sample two | Sample three | Sample four | Sample five | Sample six |
|---|---|---|---|---|---|---|---|---|
| Wild type | AATTTATTATCGTACTTTATTTTATATAG | |||||||
| H1 | ---------------------------------------------------- | 17 | 8 | 9 | ||||
| H2 | --------------TG------------------------G-------- | 14 | 1 | 9 | 4 | |||
| H3 | --------------TG----------C---G-------G-------- | 1 | 1 | |||||
| H4 | --------C----TG------------------------G--------- | 1 | 1 | |||||
| H5 | --------------TG----C------------------G--------- | 1 | 1 | |||||
| H6 | ---------C---TG------------C----------G--------- | 1 | 1 | |||||
| H7 | --------------TG------G----------------G--------- | 1 | 1 | |||||
| H8 | ------C------TG------------------------G--------- | 1 | 1 | |||||
| H9 | --------------TG------------------------GC-------- | 1 | 1 | |||||
| H10 | ------------CTG------------------------G--------- | 1 | 1 | |||||
| H11 | ----C--------TG------------------------G--------- | 1 | 1 | |||||
| H12 | --------------TG------------------------G------G- | 1 | 1 | |||||
| H13 | ---------CC-TG-------T--------------- G--------- | 1 | 1 | |||||
| H14 | --G----------TG------------------------G--------- | 1 | 1 | |||||
| H15 | G------------TGT---------------------- G--------- | 1 | 1 | |||||
| H16 | ------------------------------------C-------------- | 7 | 7 | |||||
| H17 | -------------------------------------C-C----------- | 1 | 1 | |||||
| H18 | -------------------------------------C--------A---- | 1 | 1 | |||||
| H19 | --------------------T----------C-------------------- | 1 | 1 | |||||
| H20 | ---------------------------------------------------A | 1 | 1 | |||||
| H21 | -----------------------------------C---------G------ | 1 | 1 | |||||
| Total | 7 | 2 | 7 | 3 | 3 | 2 |
aStandard reference sources of mtND2 gene sequence: GenBank (AP003317), no involving the whole genome sequence.
Figure 1Positive control plasmid for pyrosequencing. The Sanger sequencing peak map (a) and the pyrosequencing peak map in complement strand (b) for the positive control clone that contains mt.5703T and mt.5727G alleles. The Sanger sequencing peak map (c) and the pyrosequencing peak map in complement strand (d) for the positive control clone that contains mt.5703 A and mt.5727 T alleles.
The heteroplasmic sites, mt.T5727G and mt.A5703T, in chicken breast muscle from different development periods.
| Periods | mt.T5727G | mt.A5703T | ||
|---|---|---|---|---|
| Allele T | Allele G | Allele A | Allele T | |
| E12 (n = 3) | 100.0 | 0.0 | 100.0 | 0.0 |
| E14 (n = 3) | 100.0 | 0.0 | 100.0 | 0.0 |
| E17 (n = 1) | 72.2 | 27.9 | 74.4 | 25.6 |
| E17 (n = 2) | 100.0 | 0.0 | 100.0 | 0.0 |
| D1 (n = 3) | 100.0 | 0.0 | 100.0 | 0.0 |
| D7 (n = 2) | 100.0 | 0.0 | 100.0 | 0.0 |
| D7 (n = 1) | 3.1 | 96.9 | 7.0 | 93.0 |
The heteroplasmic sites, mt.T5727G and mt.A5703T, in different tissues from the same individuals.
| Sample | mt.T5727G | mt.A5703T | ||
|---|---|---|---|---|
| Allele T | Allele G | Allele A | Allele T | |
| Breast muscle | 3.1 | 96.9 | 7.0 | 93.0 |
| Leg muscle | 3.6 | 96.4 | 5.2 | 94.8 |
| Bursa of fabricii | 45.8 | 54.2 | 52.2 | 47.8 |
| Cerebrum | 100.0 | 0.0 | 100.0 | 0.0 |
| Cerebellum | 100.0 | 0.0 | 100.0 | 0.0 |
| Intestines | 100.0 | 0.0 | 100.0 | 0.0 |
| Kidney | 100.0 | 0.0 | 100.0 | 0.0 |
| Lung | 100.0 | 0.0 | 100.0 | 0.0 |
| Liver | 100.0 | 0.0 | 100.0 | 0.0 |
| Glandular stomach | 100.0 | 0.0 | 100.0 | 0.0 |
| Muscular stomach | 100.0 | 0.0 | 100.0 | 0.0 |
| Heart | 100.0 | 0.0 | 100.0 | 0.0 |
Figure 2Comparisons of predominant allele frequency for mt.T5727G and mt.A5703T sites between 30% energy restriction group (ER) and ad libitum group (AL). (a) mt.T5727G site; (b) mt.A5703T site. n = 20 for each group. NS means no significance.
Figure 3Comparisons of predominant allele frequency for the mt.T5727G and mt.A5703T sites among different fat treatment group. (a) The mt.T5727G site; (b) the mt.A5703T site. LO, 5% linseed oil group; SO, 5% sesame oil group; LG, 5% lard grease group; CO, 5% corn oil group. n = 5 for each group. NS means no significance.